Last edition
News about "Takeda Pharmaceutical "
Alloy Therapeutics Signs License Deal with Takeda to Develop Cell Therapy Platform
Under the agreement, Alloy gains co-exclusive rights to commercialize iCAR-T and iCAR-NK products for oncology indications.
Takeda Pharmaceutical | 21/11/2024 | By Aishwarya
Cipla and Takeda to Commercialize Vonoprazan in India
Cipla has signed a non-exclusive Patent License agreement with Takeda Pharmaceutical company Ltd. for ‘Vonoprazan’ for India Market for treating acid-related illnesses among patients.
Takeda Pharmaceutical | 27/06/2024 | By Aishwarya | 267
Sun Pharma Signs Non-Exclusive Patent Licensing Deal with Takeda for Vonoprazan
Sun Pharma has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Ltd. to commercialise Vonoprazan tablets 10 mg, 20 mg in India under the brand name Voltapraz.
Takeda Pharmaceutical | 24/06/2024 | By Aishwarya | 305
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy